Invasive pulmonary aspergillosis in the post-COVID-19 era: diagnosis, treatment, and what lies ahead
Therapeutic Advances in Infectious Disease
Published online on February 13, 2026
Abstract
Therapeutic Advances in Infectious Disease, Volume 13, January-December 2026.
Invasive pulmonary aspergillosis (IPA) is a severe opportunistic fungal infection that predominantly affects immunocompromised individuals, including those with hematologic malignancies, organ transplants, and, more recently, patients with post-COVID-19 ...
Invasive pulmonary aspergillosis (IPA) is a severe opportunistic fungal infection that predominantly affects immunocompromised individuals, including those with hematologic malignancies, organ transplants, and, more recently, patients with post-COVID-19 ...